000 | 02689 a2200721 4500 | ||
---|---|---|---|
005 | 20250516074342.0 | ||
264 | 0 | _c20120521 | |
008 | 201205s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2011-03-345306 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOhnuki, Hidetaka | |
245 | 0 | 0 |
_aBAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis. _h[electronic resource] |
260 |
_bBlood _cMar 2012 |
||
300 |
_a2688-98 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Communication |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aChromatin Immunoprecipitation |
650 | 0 | 4 |
_aCullin Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xmetabolism |
650 | 0 | 4 |
_aImmunoglobulin J Recombination Signal Sequence-Binding Protein _xantagonists & inhibitors |
650 | 0 | 4 | _aImmunoprecipitation |
650 | 0 | 4 |
_aLuciferases _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMorphogenesis |
650 | 0 | 4 | _aNeovascularization, Physiologic |
650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
650 | 0 | 4 |
_aPolyubiquitin _xmetabolism |
650 | 0 | 4 |
_aPseudopodia _xmetabolism |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 |
_aReceptors, Notch _xantagonists & inhibitors |
650 | 0 | 4 |
_aRepressor Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aRetina _xcytology |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSkin _xinjuries |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
650 | 0 | 4 | _aWound Healing |
700 | 1 | _aInoue, Hirofumi | |
700 | 1 | _aTakemori, Nobuaki | |
700 | 1 | _aNakayama, Hironao | |
700 | 1 | _aSakaue, Tomohisa | |
700 | 1 | _aFukuda, Shinji | |
700 | 1 | _aMiwa, Daisuke | |
700 | 1 | _aNishiwaki, Eiji | |
700 | 1 | _aHatano, Masahiko | |
700 | 1 | _aTokuhisa, Takeshi | |
700 | 1 | _aEndo, Yaeta | |
700 | 1 | _aNose, Masato | |
700 | 1 | _aHigashiyama, Shigeki | |
773 | 0 |
_tBlood _gvol. 119 _gno. 11 _gp. 2688-98 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2011-03-345306 _zAvailable from publisher's website |
999 |
_c21492930 _d21492930 |